Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BRETEC.HE
- Price
- 1.74
- Stock movement down
- -0.03 (-1.92%)
- Company name
- Exchange
- (HE ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 39.25M
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -54.63%
- 3 year return
- -12.83%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-16
DIVIDENDS
BRETEC.HE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.30 |
| Daily high | 1.30 |
| Daily low | 1.22 |
| Daily Volume | 143K |
| All-time high | 3.26 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BRETEC.HE | S&P500 | |
| Current price drop from All-time high | -60.89% | -0.80% |
| Highest price drop | -60.89% | -56.47% |
| Date of highest drop | 19 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -27.58% | -10.99% |
| Avg time to new high | 98 days | 12 days |
| Max time to new high | 598 days | 1805 days |
COMPANY DETAILS
Marketcap
39.25M
Marketcap category
Small-cap
Description
Employees
Investor relations
-
SEC filings
CEO
Country
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company"), announced through a press release a new sales and distribution agreement with Tri-State Biologics ("TSB"), enabling the sale and distri...
October 27, 2025
On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company"), announced that the revised timeline of the planned commercialization of the DrillPin in the U.S. was then not expected to have a mater...
October 27, 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the co...
October 1, 2025
Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB).
September 4, 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of th...
September 2, 2025
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer (CEO) effective immediately. Van Hellenberg ...
August 27, 2025
Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST
August 14, 2025
Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST
June 27, 2025
Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST
June 24, 2025
Bioretec Ltd ("Bioretec" or the "Company") announced on 28 May 2025 that the Board of Directors of Bioretec has decided to offer Bioretec's shareholders up to 6,156,618 new shares (the "New Shares") f...
June 23, 2025
Next page